SynAct
SYNACT.STSynAct Pharma AB Price (SYNACT.ST)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
32,523,854
(17.9041)%Revenue and Profitability
| Year | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Net Income | -937,000 | -982,000 | -15,455,945 | -15,395,165 | -23,445,381 | -23,957,721 | -26,551,000 | -69,304,000 | -99,205,000 | -215,810,000 | - |
| FCF USD | 0 | 0 | -15,636,576 | -17,466,268 | -24,214,950 | -16,622,516 | -33,239,000 | -64,997,000 | -117,555,000 | -100,177,000 | -89,197,000 |
| OCF USD | 0 | 0 | -14,733,613 | -17,201,772 | -24,214,950 | -16,123,518 | -33,239,000 | -64,997,000 | -117,555,000 | -100,177,000 | -89,197,000 |
Financial Health - DEBT
| Year | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YTPD | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.03 | -0.01 | 0.00 | -0.01 |
| D/E | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.15 | 0.02 | 0.00 | 0.01 |
| CA/CL | 4.12 | 1.46 | 8.44 | 6.08 | 3.53 | 0.82 | 3.73 | 2.27 | 9.34 | 3.01 | 3.30 |
| TA/TL | 8.93 | 6.61 | 8.75 | 6.58 | 3.77 | 2.31 | 3.77 | 2.19 | 8.87 | 4.40 | 4.80 |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3,089,000 | 2,064,000 | 637,000 | 1,881,000 |
Management Performance
| Year | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROIC | -79.83% | -154.01% | -57.02% | -120.26% | -228.53% | -162.34% | -167.22% | -288.86% | -76.17% | -106.07% | - |
| ROE | 23.67% | 20.49% | -57.08% | -119.23% | -227.35% | -177.42% | -167.32% | -332.09% | -78.41% | -122.49% | - |
| ROA | 0.00% | -260.48% | -50.56% | -119.48% | -202.37% | -104.15% | -144.88% | -199.90% | -74.13% | -94.65% | -33.26% |
| NM % | - | - | - | - | - | - | - | - | - | - | - |
| FCF / R% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| FCF / NI% | 0.00% | 0.00% | 101.17% | 96.01% | 85.29% | 67.02% | 106.25% | 84.74% | 111.21% | 46.42% | 99.13% |
| Operating Margin (OM) | - | - | - | - | - | - | - | - | - | - | - |
Per Share
| Year | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | -0.13 | -0.14 | -1.30 | -1.24 | -1.70 | -1.62 | -1.23 | -2.67 | -3.60 | -6.64 | 0.00 |
| SPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| OCPS | 0.00 | 0.00 | -1.24 | -1.38 | -1.75 | -1.09 | -1.54 | -2.50 | -4.26 | -3.08 | 0.00 |
| FCPS | 0.00 | 0.00 | -1.32 | -1.41 | -1.75 | -1.12 | -1.54 | -2.50 | -4.26 | -3.08 | 0.00 |
| BVPS | 0.09 | 0.04 | 2.28 | 1.04 | 0.75 | 0.91 | 0.73 | 0.80 | 4.59 | 5.42 | 0.00 |
Per Share - CAGR
| Year | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CAGR-EPS | -0.13 | -0.14 | -1.30 | -1.24 | -1.70 | -1.62 | -1.23 | -2.67 | -3.60 | -6.64 | 0.00 |
| CAGR-SPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CAGR-OCPS | 0.00 | 0.00 | -1.24 | -1.38 | -1.75 | -1.09 | -1.54 | -2.50 | -4.26 | -3.08 | 0.00 |
| CAGR-FCPS | 0.00 | 0.00 | -1.32 | -1.41 | -1.75 | -1.12 | -1.54 | -2.50 | -4.26 | -3.08 | 0.00 |
| CAGR-BVPS | 0.09 | 0.04 | 2.28 | 1.04 | 0.75 | 0.91 | 0.73 | 0.80 | 4.59 | 5.42 | 0.00 |